HIGH

Ascend Laboratories Recalls Atorvastatin Calcium 80 mg Tablets (90-Count & 500-Count) for Failed Dil

Ascend Laboratories recalls Atorvastatin Calcium Tablets USP, 80 mg, in 90-count and 500-count packages nationwide. The recall cites failed dissolution specifications. Health care providers and patients should stop using the recalled tablets and seek guidance from Ascend or their prescribers.

Quick Facts at a Glance

Recall Date
September 19, 2025
Hazard Level
HIGH
Brand
Ascend Laboratories
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Ascend Laboratories, LLC or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Atorvastatin Calcium is a prescription statin used to lower cholesterol. Patients obtain this medication through pharmacies under physician guidance.

Why This Is Dangerous

If the tablet does not dissolve properly, the amount of active drug released can be inconsistent, potentially reducing efficacy or causing unexpected dosing.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients may experience reduced cholesterol management effectiveness or require a change in medication. No injuries have been reported in connection with this recall so far.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC: 67877-514-90 or 67877-514-05.
  2. Check Lot numbers listed on the package (e.g., Lot#: 25140249).
  3. Check expiration date on the package (dates through 2026).
  4. Keep packaging until instructed by Ascend.

Where to find product info

Recall details available via the FDA enforcement report and Ascend Laboratories communications. Look for the lot numbers and expiration dates on the vial or bottle label.

What timeline to expect

The recall notice does not specify a refund or replacement timeline. Expect follow-up communications from Ascend Laboratories.

If the manufacturer is unresponsive

  • Document all communications with Ascend Laboratories.
  • File a complaint with the FDA if the company is unresponsive.
  • Keep receipts and packaging for documentation.

How to prevent similar issues

  • Always verify NDC, lot number, and expiration date before dispensing or consuming any medication.
  • Ask your pharmacist about any recalls on prescribed medications.
  • Register recall updates with your pharmacy or healthcare provider to receive immediate notifications.

Documentation advice

Retain Recall notification, original packaging, and all correspondence. Photograph the packaging and vial label for records.

Product Details

NDC 67877-514-90 (90-count) and NDC 67877-514-05 (500-count). Manufacturer: Alkem Laboratories, Ltd. India. Distributed by Ascend Laboratories, LLC, Parsippany, NJ 07054. Generic: Atorvastatin Calcium. Brand: Atorvastatin Calcium. Distribution: U.S. Nationwide. Recall date: 2025-09-19. Status: Active.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 2 NDCs: 67877-514-90 and 67877-514-05
  • 90-count and 500-count packages
  • Country of manufacture: India
  • Distribution: Nationwide in the U.S.
  • Recall date: 2025-09-19
  • Status: Active

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
Lot#: 25140249
Exp. Dec. 2026 Lot#: 25140247
Exp. Dec. 2026 Lot#: 24144999
Exp. Nov. 2026 Lot#: 24144942
Exp. Nov. 2026 Lot#: 24144845
+6 more
UPC Codes
67877-511
67877-512
67877-513
+11 more
Affected States
ALL
Report Date
October 22, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more
Vehicles & Parts
HIGH

Chrysler Pacifica Radio Recall 2025 Over Rearview Camera Display Issue

Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.

Chrysler
A rearview
Read more